$LRCX

Fernandes Neil J sold $2.4M of LRCX

Fernandes Neil J (Senior Vice President) sold 7,659 shares of LAM RESEARCH CORP (LRCX) at $309.60 ($2.37M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Fernandes Neil J
Published Jun 2, 2026, 4:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 4:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LRCX
Neutral
medium confidence
Mentioned
$LRCX
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LRCXNeutralLow
01

Why it matters

The disclosure provides a datapoint on insider liquidity/portfolio management but does not, by itself, change fundamentals or forward expectations.

02

Market read

Expect limited incremental impact; any trading reaction is likely sentiment-driven and short duration.

03

What to watch

Traders may overweight Form 4s; the plan’s pre-arranged nature and modest share count relative to float reduce predictive value.

Relevance 4/10Novelty 3/10Timing: Filed 2026-06-02; sale executed 2026-06-01.

Background

This is an SEC Form 4 insider transaction disclosure (officer/direct holdings) for LAM Research Corp.

Company-level read

Ticker impact

$LRCXNeutralMedium confidence
Context

LRCX SVP Fernandes Neil J sold 7,659 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any effect would be short-lived.

Evidence & confidence

The filing is a routine officer sale under a 10b5-1 plan, with no accompanying fundamental catalyst or guidance change reported.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide shock.

None indicated.

None indicated.

Counterpoint

A 10b5-1 sale can still coincide with internal rebalancing needs; absence of buying may be less informative than the broader tape.

Key entities

  • LAM Research Corp

    Subject of the Form 4 insider sale by an officer under a 10b5-1 plan.

  • Fernandes Neil J

    Senior Vice President who sold 7,659 shares on 2026-06-01.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LRCXMed

The Memory Crunch Is Bigger Than Expected. 1 Top Stock to Buy on the Dip (Hint: Not Micron or Sandisk)

Lam Research (LRCX) is benefiting from a memory chip supply crunch, with revenue up 26% and earnings up 39% in fiscal 2026. The company expects 52% revenue growth and 71% earnings growth in the current quarter. Deloitte projects memory manufacturer capex to rise significantly, favoring Lam's semiconductor equipment sales. Analysts forecast 62% EPS growth for fiscal 2027, with potential for further upside.

$LRCXMedAI 8/10

Ministry approves Lam Research's NT$9.8 billion Taiwan investment

Taiwan's Ministry of Economic Affairs approved Lam Research's NT$9.835 billion (US$310 million) investment in its Taiwan subsidiary for semiconductor equipment R&D. Other approved investments include Zhen Ding Technology's NT$3 billion in Boardtek Electronics, Nuvoton's 15 billion yen in its Japan unit, and Foxconn's US$57.01 million in Mitsubishi Fuso Bus.